IP Verse

Compositions Comprising Sphingosine I Phosphate (Sip) Receptor Modulators - EP2952177

The patent EP2952177 was granted to Novartis on Jan 20, 2021. The application was originally filed on Oct 9, 2008 under application number EP15173766A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2952177

NOVARTIS
Application Number
EP15173766A
Filing Date
Oct 9, 2008
Status
Granted And Under Opposition
Dec 18, 2020
Publication Date
Jan 20, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSMay 4, 2023D YOUNGINTERVENTION WITHDRAWN
TEVA PHARMACEUTICALSSep 22, 2022D YOUNGINTERVENTION WITHDRAWN
ACCORD HEALTHCAREOct 20, 2021HOFFMANN EITLEWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2005025553
OPPOSITIONEP0812588
OPPOSITIONEP1201236
OPPOSITIONWO2004089341
OPPOSITIONWO2005002559
OPPOSITIONWO2005025553
OPPOSITIONWO2006102611
SEARCHWO2004089341
SEARCHWO2007021666
SEARCHWO2008037421

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- W.A Ritschel ET AL, "Die Tablette", der Pharmazeutische Betrieb, (20020101), page 68, ISBN 978-3-87193-228-1, XP055464317
OPPOSITION- Augsburger L.L. Et Al., "Tablet formulation", Augsburger L.L. Et Al., James Swarbrick, Encyclopedia of Pharmaceutical Technology, (20070101), pages 3641 - 3652, XP055449019
OPPOSITION- Augsburger L.L. Et Al., "Tablet formulation", Augsburger L.L. Et Al., James Swarbrick, Encyclopedia of Pharmaceutical Technology, Informa Healthcare, (20070101), pages 3641 - 3652, XP055449019
OPPOSITION- "Handbook of Pharmaceutical Excipients Fifth Edition /Passage/", Rowe Raymond C, Paul J Sheskey, Sian C Owen, Handbook of Pharmaceutical Excipients Fifth Edition, Pharmaceutical Press, (20060101), pages 130-135, 188-191, 211-213, 336-340, 346-349, 385-398, 611-616, 701-704 and 725 - 733, XP055970567
OPPOSITION- JAMES WELLS, "PHARMACEUTICAL PREFORMULATION: THE PHYSICOCHEMICAL PROPERTIES OF DRUG SUBSTANCES.", JAMES WELLS, AULTON M.E. (ED.).2, PHARMACEUTICS. THE SCIENCE OF DOSAGE FORM DESIGN ED. 2, CHURCHILL LIVIGSTONE , (20020101), pages I - 113-138, 027702, ISBN 978-0-443-05517-1, XP003035880
OPPOSITION- JAMES WELLS, "PHARMACEUTICAL PREFORMULATION: THE PHYSICOCHEMICAL PROPERTIES OF DRUG SUBSTANCES.", JAMES WELLS, AULTON M.E., PHARMACEUTICS. THE SCIENCE OF DOSAGE FORM DESIGN ED. 2, CHURCHILL LIVIGSTONE , (20020101), pages I-III - 113 - 138, 027702, ISBN 978-0-443-05517-1, XP003035880
OPPOSITION- Kumar Vijay, Gilbert S. Banker, "MAILLARD REACTION AND DRUG STABILITY", Kumar Vijay, Gilbert S. Banker, Labuza T P; REineccius G A; Monnier V M; Brien J O; Baynes J W, Maillard Reactions in Chemistry, Food, and Health, Woodhead Publishing, (20050101), pages 20 - 27, XP055970559
OPPOSITION- Kumar Vijay, Gilbert S. Banker, "MAILLARD REACTION AND DRUG STABILITY", Kumar Vijay, Gilbert S. Banker, T.P. Labuza, G.A REineccius, V.M. Monnier, J.O Brien, J.W. Baynes, Maillard Reactions in Chemistry, Food, and Health, Woodhead Publishing, (20050101), pages 20 - 27, XP055970559
OPPOSITION- "Racemization", G.S. Banker, Et Al, Modern Pharmaceutics, 4th ed. Rev. and Exp., New York , Marcel Dekker , (20020101), pages 222-223, 253 - 254, XP055314922
OPPOSITION- W.A Ritschel, A. Bauer-Brandl, "Die Tablette", W.A Ritschel, A. Bauer-Brandl, RITSCHEL W.A., Die Tablette Handbuch der Entwicklung, Herstellung und Qualitätssicherung, EDITIO CANTOR VERLAG , (20020101), page 68, ISBN 978-3-87193-228-1, XP055464317
OPPOSITION- W.A. RITSCHEL et al., Die Tablette - Handbuch der Entwicklung, Herstellung und Qualitätssicherung, (20020000), page 68, XP055464317
OPPOSITION- Kosugi Atsushi, Leong Kok Hoong, Tsuji Hinako, Hayashi Yoshihiro, Kumada Shungo, Okada Kotaro, Onuki Yoshinori, "Characterization of Powder- and Tablet Properties of Different Direct Compaction Grades of Mannitol Using a Kohonen Self-organizing Map and a Lasso Regression Model", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, US , (20200801), vol. 109, no. 8, doi:10.1016/j.xphs.2020.05.010, ISSN 0022-3549, pages 2585 - 2593, XP009551989

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents